A new review of 12 studies found gut microbiome changes in patients with immune thrombocytopenia, though results were inconsistent across populations and methods.
In a UK-wide analysis of nearly 2 million patients, researchers found that “a fifth of patients receiving corticosteroids accounted for over 80% of oral and inhaled corticosteroid prescribing,” highlighting concentrated use and variable treatment persistence across formulations.
In a multicenter study of over 600 patients, researchers found that higher fecal hemoglobin levels and smoking increased the likelihood of needing a follow-up colonoscopy after capsule endoscopy.
The FDA has cleared IB-Stim as the first treatment specifically indicated for pediatric functional dyspepsia and related nausea, providing a noninvasive neuromodulation option for abdominal pain in patients aged 8 to 21 years.